Invention Grant
- Patent Title: Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
-
Application No.: US13927244Application Date: 2013-06-26
-
Publication No.: US09254309B2Publication Date: 2016-02-09
- Inventor: Jose Courty , Ara Hovanessian , Jean Paul Briand , Gilles Guichard , Yamina Hamma
- Applicant: Centre National De La Recherche Scientifique
- Applicant Address: FR Paris
- Assignee: Centre National De La Recherche Scientifique (CNRS)
- Current Assignee: Centre National De La Recherche Scientifique (CNRS)
- Current Assignee Address: FR Paris
- Agency: Locke Lord LLP
- Agent Bryan D. Zerhusen
- Priority: FR0603813 20060427
- Main IPC: C07K7/02
- IPC: C07K7/02 ; C07K5/02 ; A61K38/03 ; C07K11/00 ; A61K38/16 ; A61K38/02 ; C07K14/47
Abstract:
A method for treating disorders involving deregulation of cell proliferation and/or angiogenesis comprising the administration of an effective amount of a multivalent synthetic compound comprising a support on which at least 3 pseudopeptide units are grafted, said compound being of formula (I).
Public/Granted literature
- US20140073555A1 USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE NUCLEOLIN FOR TREATING CANCER OR INFLAMMATION Public/Granted day:2014-03-13
Information query
